ALTILAN company officially presented ORBITAS – revolutionary cloud platform, which uses artificial intelligence to radically accelerate the feasibility study stage (feasibility study) space production missions.
It is traditionally estimated that, whether it is profitable to produce a certain material or drug in microgravity conditions, takes from 3 to 6 months and requires the involvement of a team of experts. ORBITAS shortens this process to 10 minutes, analyzing physical, technical and economic parameters of the mission.
Key features of the platform:
Automated modeling: The platform calculates, how microgravity will affect the crystallization of proteins, growth of nanomaterials or semiconductor production.
Choosing the optimal platform: The system compares different production location options – from the International Space Station (ISS) to automated capsules, such as Varda Space or Space Forge.
Logistics and returns: ORBITAS calculates the start-up cost, the length of stay in orbit and the difficulty of safely returning the cargo to Earth.
Economic analytics: The platform issues a profitability forecast (ROI), helping companies understand, will the market price of the product justify the high cost of space production.
Why this is important for the In-Space Manufacturing market (ISM)?
By this time high “entrance threshold” (the need for in-depth knowledge of space physics and complex calculations) deterred pharmaceutical and technology giants from experimenting in orbit.
The purpose of ALTILAN – make space available for normal business, turning it from an exotic scientific site into a full-fledged production workshop.
Thanks to ORBITAS, companies can weed out unviable ideas in minutes and focus on projects, which have the greatest commercial potential in the field of regenerative medicine and materials science.
Source: https://uchubiz.com